With DNA damage induced by alkylating agents in tumor cells, PARP1 reduces the affinity of EZH2 for H3K27 sites and inhibits its enzymatic activity through PARylation, while poly ADP-ribose glycohydrolase (PARG) can reverse this effect (Caruso et al., 2018). The gene discussed is PARP1; the disease is neoplasm.